PeopleBio Co (XKRX:304840) Total Liabilities : ₩6,906 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PeopleBio Co Total Liabilities?

PeopleBio Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩6,906 Mil.

PeopleBio Co's quarterly Total Liabilities declined from Sep. 2023 (₩26,835.34 Mil) to Dec. 2023 (₩7,916.57 Mil) and declined from Dec. 2023 (₩7,916.57 Mil) to Mar. 2024 (₩6,906.48 Mil).

PeopleBio Co's annual Total Liabilities increased from Dec. 2021 (₩32,331.61 Mil) to Dec. 2022 (₩36,391.78 Mil) but then declined from Dec. 2022 (₩36,391.78 Mil) to Dec. 2023 (₩7,916.57 Mil).

PeopleBio Co Total Liabilities Historical Data

The historical data trend for PeopleBio Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PeopleBio Co Total Liabilities Chart

PeopleBio Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,655.10

1,826.99

32,331.61

36,391.78

7,916.57

PeopleBio Co Quarterly Data
	Jun19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial													33,934.26	26,037.07	26,835.34	7,916.57	6,906.48

PeopleBio Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PeopleBio Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3533.167	+	(1113.704	+	146.171
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3123.531)
	=	7,917

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	27580.457	-	19663.884
	=	7,917

PeopleBio Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2518.131	+	(999.023	+	151.526
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3237.8)
	=	6,906

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	23032.193	-	16125.714
	=	6,906

PeopleBio Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of PeopleBio Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PeopleBio Co (XKRX:304840) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PeopleBio Co Ltd (XKRX:304840) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

242 Pangyo-ro, 6th Floor, PDC C-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

http://www.peoplebio.net

PeopleBio Co Ltd is a biotechnology company. The company is engaged in the business of developing diagnostic products for neurodegenerative diseases. The company's technology, Multimer Detection System (MDS), helps in detecting protein misfolding diseases like Alzheimer's disease, Parkinson's disease, and Creutzfeldt-Jakob's disease.

PeopleBio Co (XKRX:304840) Headlines

No Headlines